Iron Triangle Partners’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,843,278
| Closed | -$18.1M | – | 34 |
|
|
2023
Q4 | $18.1M | Buy |
1,843,278
+43,278
| +2% | +$425K | 2.34% | 21 |
|
|
2023
Q3 | $15M | Sell |
1,800,000
-600,000
| -25% | -$5.01M | 2.2% | 20 |
|
|
2023
Q2 | $31.9M | Buy |
2,400,000
+100,000
| +4% | +$1.33M | 4.27% | 10 |
|
|
2023
Q1 | $26.6M | Buy |
2,300,000
+600,000
| +35% | +$6.95M | 3.84% | 13 |
|
|
2022
Q4 | $13.9M | Sell |
1,700,000
-1,300,000
| -43% | -$10.6M | 2.49% | 17 |
|
|
2022
Q3 | $17.4M | Buy |
+3,000,000
| New | +$17.4M | 3.04% | 17 |
|
|
2021
Q3 | – | Sell |
-976,245
| Closed | -$34.1M | – | 30 |
|
|
2021
Q2 | $34.1M | Buy |
976,245
+40,440
| +4% | +$1.41M | 3.52% | 15 |
|
|
2021
Q1 | $31.2M | Buy |
935,805
+135,805
| +17% | +$4.52M | 3.96% | 13 |
|
|
2020
Q4 | $20.8M | Sell |
800,000
-1,200,000
| -60% | -$31.1M | 2.69% | 16 |
|
|
2020
Q3 | $19.7M | Buy |
+2,000,000
| New | +$19.7M | 4.41% | 10 |
|